World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
115
Citations
64456
World Ranking
300
National Ranking
180

Yue Xiong publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Yue Xiong sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 256 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Yue Xiong D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Yue Xiong sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 115 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Yue Xiong is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on Biochemistry, Genetics, and Molecular Biology, with significant contributions in Medicine. Within these broader fields, they have delved extensively into subfields such as Molecular Biology, Cancer Research, Immunology, Epidemiology, and Biomedical Engineering.

The major topics covered in Yue Xiong's work include:

  • Ubiquitin and proteasome pathways
  • Extracellular vesicles in disease
  • Epigenetics and DNA Methylation
  • Protein Degradation and Inhibitors
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer
  • Liver Disease Diagnosis and Treatment

Yue Xiong has published numerous papers in various reputable venues. Frequent publication platforms include:

  • Science Advances
  • UNC Libraries
  • Frontiers in Cell and Developmental Biology
  • Chemical Engineering Journal
  • Journal of Medicinal Chemistry

Recent notable publications by Yue Xiong are:

  • "Advancing targeted protein degradation for cancer therapy," 2021, Nature reviews. Cancer
  • "Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity," 2020, Liver International
  • "Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses," 2022, Nature Cell Biology
  • "Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders," 2020, Journal of Medicinal Chemistry
  • "Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis," 2022, Journal of Hepatology

Collaboration forms an important aspect of Yue Xiong's scientific activity. Frequent co-authors include Kun-Liang Guan, Yiping Sun, Dan Ye, Wenbin Deng, and Jian Jin.

Yue Xiong was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2011.

Best Publications

  • p21 is a universal inhibitor of cyclin kinases

    Yue Xiong;Gregory J. Hannon;Gregory J. Hannon;Hui Zhang;Hui Zhang;David Casso;David Casso

  • Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

    Wei Xu;Hui Yang;Ying Liu;Ying Yang

  • Regulation of cellular metabolism by protein lysine acetylation.

    Shimin Zhao;Wei Xu;Wenqing Jiang;Wei Yu

  • ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

    Yanping Zhang;Yue Xiong;Wendell G Yarbrough

  • Origin and evolution of retroelements based upon their reverse transcriptase sequences.

    Yue Xiong;T. H. Eickbush

  • D Type Cyclins Associate with Multiple Protein Kinases and the DNA Replication and Repair Factor PCNA

    Yue Xiong;Hui Zhang;David Beach

  • Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

    Shimin Zhao;Yan Lin;Wei Xu;Wenqing Jiang

  • Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters

    Tiffany Hung;Yulei Wang;Michael F. Lin;Michael F. Lin;Ashley K. Koegel

  • Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts

    D A Alcorta;Y Xiong;D Phelps;G Hannon

  • Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

    Michael B. Datto;Yan Li;Joanne F. Panus;David J. Howe

  • Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.

    Qijun Wang;Yakun Zhang;Chen Yang;Hui Xiong;Hui Xiong

  • Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.

    Y Kotake;T Nakagawa;K Kitagawa;S Suzuki

  • Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

    Mengtao Xiao;Hui Yang;Wei Xu;Shenghong Ma

  • Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.

    K L Guan;C W Jenkins;Y Li;M A Nichols

  • TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway

    Qun Ying Lei;Heng Zhang;Bin Zhao;Zheng Yu Zha

  • Human D-type cyclin

    Yue Xiong;Tim Connolly;Bruce Futcher;David Beach

  • BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.

    Manabu Furukawa;Yue Xiong

  • Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.

    Yue Xiong;Hui Zhang;David Beach

  • Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

    Yanping Zhang;Gabrielle White Wolf;Krishna P Bhat;Aiwen Jin

  • Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation

    Yang H;Liu Y;Bai F;Zhang Jy

Frequent Co-Authors

Kun-Liang Guan
Kun-Liang Guan Westlake University
Qun-Ying Lei
Qun-Ying Lei Fudan University
David Beach
David Beach Cold Spring Harbor Laboratory
Yan Lin
Yan Lin Shanghai Jiao Tong University
Thomas H. Eickbush
Thomas H. Eickbush University of Rochester
Xian Chen
Xian Chen University of North Carolina at Chapel Hill
Lishan Su
Lishan Su University of Maryland, Baltimore
Jun Yao
Jun Yao China University of Petroleum, Beijing
Yi Zhang
Yi Zhang Harvard University
Gregory J. Hannon
Gregory J. Hannon University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in taking your Molecular Biology background into the healthcare sector, there are several online degree options to consider. Many students explore careers in nursing or advanced practice roles, which offer thriving job markets and meaningful work.

One common pathway is nursing, where students often ask how long does it take to become a nurse practitioner. The route to becoming a nurse practitioner can be accelerated via various online programs designed for students with different backgrounds and schedules.

For registered nurses seeking career advancement, choosing the shortest rn to bsn program may be ideal for quickly obtaining a bachelor’s degree and broadening career options. Similarly, those holding an associate degree in nursing can transition into specialized roles through asn to fnp programs.

Even non-nurses with a molecular biology background can make a swift career change through msn direct entry programs online. These programs help science graduates enter the nursing profession without starting from scratch, leveraging their scientific training for a rewarding new path.

Best Scientists Citing Yue Xiong

Trending Scientists

Recently Published Articles